In this study, the authors identified dasatinib as a drug that can temporarily inactivate CAR T cells to help reduce acute toxicity, allowing the T cells to recover their antitumor effects after the drug is withdrawn.
This review presents the mechanisms of different gene editing strategies and describes each of the common nuclease-based platforms, including zinc finger nucleases, TALE nucleases, meganucleases, and the CRISPR/Cas9 system. The authors summarize the progress made in applying genome editing to various areas of gene and cell therapy, including antiviral strategies, immunotherapies, and the treatment of monogenic hereditary disorders.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
In this study, the authors identified dasatinib as a drug that can temporarily inactivate CAR T cells to help reduce acute toxicity, allowing the T cells to recover their antitumor effects after the drug is withdrawn.